TNFSF11 and arthritic joint disease: It was reported that RANKL-targeted peptides inhibited osteoclastogenesis and attenuated adjuvant-induced arthritis by inhibiting RANKL activation and downregulating inflammatory cytokines (Naidu et al., 2013).